Home Affordability Crisis A Tale of Three Owners and Soaring Costs USChina Trade Talks Show Persistent Divergence at APEC BofA Upgrades Outlook for Philip Morris International with 9 Price Target Increase NIQ Global Intelligence CEO Buys 1 Million in Shares What It Could Signal Jim Cramers Optimistic Intuit INTU Call Precedes Sharp Stock Decline Americans Feel Inflations Strain as Holiday Weekend Approaches Travel Recreation and Food Prices Lead Surge MCO Q1 2026 Earnings EPS Surpasses Estimates Despite Modest Stock Decline Lucid Diagnostics Inc Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Diagnostics Firm Advances Product Commercialization BDCI Q1 2026 Earnings Positive EPS Emerges Amid Limited Data Altimmune Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Development Iveda Solutions Q2 2024 Earnings EPS Surpasses Estimates Despite Minimal Revenue Data Harrow Inc HROW Q1 2026 Earnings WiderThanExpected Loss but Shares Rally on Strategic Progress Ategrity Specialty Insurance Holdings ASIC Moderately Advances Hovers Near Key Technical Zone SBI Edges Higher as Western Asset Intermediate Muni Fund Holds Steady Neuberger Next Generation Connectivity Fund NBXG Advances 235 Approaching Key Resistance Tencent Music TME Holds Near 921 Support as Trading Volumes Suggest Cautious Optimism Brightstar Lottery PLC BRSL Gains 136 as Trading Begins Under New Legal Name Provident Financial Services PFS Advances 17 as It Approaches Key Resistance BioRestorative Therapies BRTX Surges 1155 to 048 Challenges Key Resistance BEPI Holds Steady Near Midpoint of Key Range Brookfield BRP Holdings Perpetual Notes Flat at 1562 Genworth Financial Slides 25 as Support Levels Come Into Focus Skillz Inc SKLZ Gains Over 6 as Stock Nears Key Resistance at 957 Olaplex Holdings OLPX Holds Steady at 205 as Key Support and Resistance Define Trading Range Guardian Investigation Reveals Asbestos Contamination in Toys Sold in Britain Spotlighting Regulatory Gaps LSCC Q1 2026 Earnings EPS Surpasses Estimates Amidst Operational Focus Cardiff Oncology CRDF Edges Lower Near Support as Volume Remains Subdued